123 related articles for article (PubMed ID: 37683642)
1. Molecular basis for the functional roles of the multimorphic T95R mutation of IRF4 causing human autosomal dominant combined immunodeficiency.
Wang G; Feng X; Ding J
Structure; 2023 Nov; 31(11):1441-1451.e3. PubMed ID: 37683642
[TBL] [Abstract][Full Text] [Related]
2. A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
; Fornes O; Jia A; Kuehn HS; Min Q; Pannicke U; Schleussner N; Thouenon R; Yu Z; de Los Angeles Astbury M; Biggs CM; Galicchio M; Garcia-Campos JA; Gismondi S; Gonzalez Villarreal G; Hildebrand KJ; Hönig M; Hou J; Moshous D; Pittaluga S; Qian X; Rozmus J; Schulz AS; Staines-Boone AT; Sun B; Sun J; Uwe S; Venegas-Montoya E; Wang W; Wang X; Ying W; Zhai X; Zhou Q; Akalin A; André I; Barth TFE; Baumann B; Brüstle A; Burgio G; Bustamante JC; Casanova JL; Casarotto MG; Cavazzana M; Chentout L; Cockburn IA; Costanza M; Cui C; Daumke O; Del Bel KL; Eibel H; Feng X; Franke V; Gebhardt JCM; Götz A; Grunwald S; Hoareau B; Hughes TR; Jacobsen EM; Janz M; Jolma A; Lagresle-Peyrou C; Lai N; Li Y; Lin S; Lu HY; Lugo-Reyes SO; Meng X; Möller P; Moreno-Corona N; Niemela JE; Novakovsky G; Perez-Caraballo JJ; Picard C; Poggi L; Puig-Lombardi ME; Randall KL; Reisser A; Schmitt Y; Seneviratne S; Sharma M; Stoddard J; Sundararaj S; Sutton H; Tran LQ; Wang Y; Wasserman WW; Wen Z; Winkler W; Xiong E; Yang AWH; Yu M; Zhang L; Zhang H; Zhao Q; Zhen X; Enders A; Kracker S; Martinez-Barricarte R; Mathas S; Rosenzweig SD; Schwarz K; Turvey SE; Wang JY
Sci Immunol; 2023 Jan; 8(79):eade7953. PubMed ID: 36662884
[TBL] [Abstract][Full Text] [Related]
3. Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.
Gross P; Yee AA; Arrowsmith CH; Macgregor RB
Biochemistry; 1998 Jul; 37(27):9802-11. PubMed ID: 9657694
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional reprogramming by mutated IRF4 in lymphoma.
Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Protein Sci; 2022 Apr; 31(4):787-796. PubMed ID: 34913532
[TBL] [Abstract][Full Text] [Related]
6. A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Thouenon R; Chentout L; Moreno-Corona N; Poggi L; Lombardi EP; Hoareau B; Schmitt Y; Lagresle-Peyrou C; Bustamante J; André I; Cavazzana M; Durandy A; Casanova JL; Galicier L; Fadlallah J; Fischer A; Kracker S
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36917008
[TBL] [Abstract][Full Text] [Related]
7. An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.
Cherian MA; Olson S; Sundaramoorthi H; Cates K; Cheng X; Harding J; Martens A; Challen GA; Tyagi M; Ratner L; Rauch D
J Biol Chem; 2018 May; 293(18):6844-6858. PubMed ID: 29540473
[TBL] [Abstract][Full Text] [Related]
8. Structural determinants of the IRF4/DNA homodimeric complex.
Sundararaj S; Seneviratne S; Williams SJ; Enders A; Casarotto MG
Nucleic Acids Res; 2021 Feb; 49(4):2255-2265. PubMed ID: 33533913
[TBL] [Abstract][Full Text] [Related]
9. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors.
Kwon H; Thierry-Mieg D; Thierry-Mieg J; Kim HP; Oh J; Tunyaplin C; Carotta S; Donovan CE; Goldman ML; Tailor P; Ozato K; Levy DE; Nutt SL; Calame K; Leonard WJ
Immunity; 2009 Dec; 31(6):941-52. PubMed ID: 20064451
[TBL] [Abstract][Full Text] [Related]
10. Phosphorus and sulfur SAD phasing of the nucleic acid-bound DNA-binding domain of interferon regulatory factor 4.
Agnarelli A; El Omari K; Duman R; Wagner A; Mancini EJ
Acta Crystallogr F Struct Biol Commun; 2021 Jul; 77(Pt 7):202-207. PubMed ID: 34196610
[TBL] [Abstract][Full Text] [Related]
11. BATF-JUN is critical for IRF4-mediated transcription in T cells.
Li P; Spolski R; Liao W; Wang L; Murphy TL; Murphy KM; Leonard WJ
Nature; 2012 Oct; 490(7421):543-6. PubMed ID: 22992523
[TBL] [Abstract][Full Text] [Related]
12. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages.
Lehtonen A; Veckman V; Nikula T; Lahesmaa R; Kinnunen L; Matikainen S; Julkunen I
J Immunol; 2005 Nov; 175(10):6570-9. PubMed ID: 16272311
[TBL] [Abstract][Full Text] [Related]
14. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
Mudter J; Yu J; Amoussina L; Weigmann B; Hoffman A; Rücknagel K; Galle PR; Neurath MF
Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.
Mudter J; Amoussina L; Schenk M; Yu J; Brüstle A; Weigmann B; Atreya R; Wirtz S; Becker C; Hoffman A; Atreya I; Biesterfeld S; Galle PR; Lehr HA; Rose-John S; Mueller C; Lohoff M; Neurath MF
J Clin Invest; 2008 Jul; 118(7):2415-26. PubMed ID: 18535667
[TBL] [Abstract][Full Text] [Related]
16. A hyperactive mutant of interferon-regulatory factor 4.
Kang CH; Hartmann E; Menke L; Staudenraus D; Abass EF; Raifer H; Porapu A; Camara B; Brüstle A; Pinkenburg O; Bieringer M; Lohoff M
Eur J Immunol; 2019 May; 49(5):812-815. PubMed ID: 30218581
[TBL] [Abstract][Full Text] [Related]
17. The dynamic functions of IRF4 in B cell malignancies.
Maffei R; Fiorcari S; Atene CG; Martinelli S; Mesini N; Pilato F; Lagreca I; Barozzi P; Riva G; Nasillo V; Paolini A; Forghieri F; Potenza L; Trenti T; Tagliafico E; Luppi M; Marasca R
Clin Exp Med; 2023 Aug; 23(4):1171-1180. PubMed ID: 36495369
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
Luo H; Tian M
Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
[TBL] [Abstract][Full Text] [Related]
19. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
20. Quantitative profiling of BATF family proteins/JUNB/IRF hetero-trimers using Spec-seq.
Chang YK; Zuo Z; Stormo GD
BMC Mol Biol; 2018 Mar; 19(1):5. PubMed ID: 29587652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
